FIRST-IN-HUMAN STUDY OF IPH5301 TREATMENT ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504605-36-00

Acronym

CHANCES-IPC 2021-008

Enrollment

Registered

2023-08-02

Start date

2022-01-21

Completion date

Unknown

Last updated

2025-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dose escalation cohort: advanced and/or metastatic cancer car-cinoma of the breast, endometri-um, esophagus, i.e HER2-positive and HER2-low breast cancer, ovary or lung. Expansion cohort: HER2-expressing, pancreas, stomach

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Belgium, France

Outcome results